Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Formononetin, a Beer Polyphenol with Catabolic Effects on Chondrocytes.
Guillán-Fresco M, Franco-Trepat E, Alonso-Pérez A, Jorge-Mora A, López-López V, Pazos-Pérez A, Piñeiro-Ramil M, Gómez R. Guillán-Fresco M, et al. Among authors: alonso perez a. Nutrients. 2023 Jun 29;15(13):2959. doi: 10.3390/nu15132959. Nutrients. 2023. PMID: 37447284 Free PMC article.
Role of Toll-Like Receptor 4 on Osteoblast Metabolism and Function.
Alonso-Pérez A, Franco-Trepat E, Guillán-Fresco M, Jorge-Mora A, López V, Pino J, Gualillo O, Gómez R. Alonso-Pérez A, et al. Front Physiol. 2018 May 8;9:504. doi: 10.3389/fphys.2018.00504. eCollection 2018. Front Physiol. 2018. PMID: 29867550 Free PMC article. Review.
Visfatin as a therapeutic target for rheumatoid arthritis.
Franco-Trepat E, Alonso-Pérez A, Guillán-Fresco M, Jorge-Mora A, Gualillo O, Gómez-Reino JJ, Gómez Bahamonde R. Franco-Trepat E, et al. Expert Opin Ther Targets. 2019 Jul;23(7):607-618. doi: 10.1080/14728222.2019.1617274. Epub 2019 May 15. Expert Opin Ther Targets. 2019. PMID: 31074669 Review.
Amitriptyline blocks innate immune responses mediated by toll-like receptor 4 and IL-1 receptor: Preclinical and clinical evidence in osteoarthritis and gout.
Franco-Trepat E, Alonso-Pérez A, Guillán-Fresco M, Jorge-Mora A, Crespo-Golmar A, López-Fagúndez M, Pazos-Pérez A, Gualillo O, Belén Bravo S, Gómez Bahamonde R. Franco-Trepat E, et al. Br J Pharmacol. 2022 Jan;179(2):270-286. doi: 10.1111/bph.15707. Epub 2021 Dec 12. Br J Pharmacol. 2022. PMID: 34643941 Free PMC article.
Repurposing drugs to inhibit innate immune responses associated with TLR4, IL1, and NLRP3 signaling in joint cells.
Franco-Trepat E, Guillán-Fresco M, Alonso-Pérez A, López-Fagúndez M, Pazos-Pérez A, Crespo-Golmar A, Gualillo O, Jorge-Mora A, Bravo SB, Gómez R. Franco-Trepat E, et al. Among authors: alonso perez a. Biomed Pharmacother. 2022 Nov;155:113671. doi: 10.1016/j.biopha.2022.113671. Epub 2022 Sep 12. Biomed Pharmacother. 2022. PMID: 36108390 Free article.
Improved Protocol to Study Osteoblast and Adipocyte Differentiation Balance.
Alonso-Pérez A, Guillán-Fresco M, Franco-Trepat E, Jorge-Mora A, López-Fagúndez M, Pazos-Pérez A, Crespo-Golmar A, Caeiro-Rey JR, Gómez R. Alonso-Pérez A, et al. Biomedicines. 2022 Dec 22;11(1):31. doi: 10.3390/biomedicines11010031. Biomedicines. 2022. PMID: 36672539 Free PMC article.
β Boswellic Acid Blocks Articular Innate Immune Responses: An In Silico and In Vitro Approach to Traditional Medicine.
Franco-Trepat E, Alonso-Pérez A, Guillán-Fresco M, López-Fagúndez M, Pazos-Pérez A, Crespo-Golmar A, Belén Bravo S, López-López V, Jorge-Mora A, Cerón-Carrasco JP, Lois Iglesias A, Gómez R. Franco-Trepat E, et al. Among authors: alonso perez a. Antioxidants (Basel). 2023 Feb 3;12(2):371. doi: 10.3390/antiox12020371. Antioxidants (Basel). 2023. PMID: 36829930 Free PMC article.
22 results